Guardian Pharmacy Services EBIT

Guardian Pharmacy Services (GRDN) currently reports a EBIT of $110M as of June 2026. That compares with $-62M in the prior-year period — up 277.6% year over year. That is above the sector sector average of $-27M. Use the charts on this page to explore Guardian Pharmacy Services's EBIT history and peer comparisons.

Guardian Pharmacy Services's EBIT increased from $-62M to $110M — a 277.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Guardian Pharmacy Services's EBIT of $110M is higher than the its sector sector average of $-27M. That is roughly 510.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Guardian Pharmacy Services reported $110M in EBIT as of June 2026. That compares with $-62M in the prior-year period — up 277.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-27M. From there, open related valuation or income-statement pages for Guardian Pharmacy Services, and consider following GRDN for alerts when major investors trade the stock.